In the 1970s, FVIII concentrates were manufactured from human plasma and proved to be effective for hemophilia treatment—but this success was short‐lived, since several patients contracted acquired immune deficiency syndrome (AIDS) that was transmitted by concentrates derived from pooled human plasma, leading to death tolls in the 1980s.42 Here, F8 is linked to AIDS.